What can recent research tell us about SSRIs and their effectiveness in treating various aspects of dementia and BPSD?
Grow your skills with an industry leader & join us on the forefront of geriatric medicine for patients in ltc
The need for quality dementia care is growing. Are your facilities ready to meet the challenge?
Prescription of anxiolytics persists in long-term care facilities. But what does the evidence say about their effectiveness?
Prevent harm, promote peaceful conflict resolution and help stabilize individuals in crisis with these de-escalation strategies.
Alzheimer's disease has a significant impact on public health. Recent research sheds light on a number of drugs that can treat the symptoms
The neurological condition commonly known as Parkinson’s disease remains the fastest-growing disease of its kind. Cases of Parkinson’s doubled from 19...
Improving quality in long-term care facilities takes a multi-faceted approach. As CMS establishes federal quality measures, it falls to the states to...
It has been forecasted that more than 152.8 million people will be living with dementia by 2050. (Morgan AE, Mc Auley MT.) With vascular dementia acco...
An injury to the brain caused by blunt trauma or penetration of brain tissue is classified by the National Institute of Neurological Disorders and Str...
n an assessment of risks vs. benefits for antipsychotics, it’s important to be able to identify individuals who may be at high risk of adverse events.
New research suggests an association between the use of gabapentin and incidence of both cognitive impairment and dementia.
